In this study, the prevalence of APOE ε4 in the AD group was significantly higher than that observed in the CU and MCI groups; however, prevalence in the MCI group was lower than that in the CU group, which may be related to the insufficient sample size in the study. This evidence concerns the gene APOE and Alzheimer disease.